IQV vs KNSA · P/E 23, rev $16.31B vs P/E 53, rev $677.6M
IQVIA Holdings Inc (IQV) versus Kiniksa Pharmaceuticals Ltd (KNSA) — a side-by-side from cached financials, not a winner call.
IQVIA Holdings Inc (IQV) is a diagnostics & research company listed on US.
Kiniksa Pharmaceuticals Ltd (KNSA) is a drug manufacturers - specialty & generic company listed on US.
Latest reported IQV revenue for 2025-12-31 was $16.31B. Net income was $1.36B. Revenue was up 5.9% from 2024-12-31 to 2025-12-31. IQV currently screens at market cap $30.62B and trailing P/E 22.8.
Latest reported KNSA revenue for 2025-12-31 was $677.6M. Net income was $59.0M. Revenue was up 60.1% from 2024-12-31 to 2025-12-31. KNSA currently screens at market cap $3.73B and trailing P/E 53.2.
IQV currently screens at market cap $30.62B and trailing P/E 22.8. KNSA currently screens at market cap $3.73B and trailing P/E 53.2.
Not investment advice. Open the IQV and KNSA stock pages for the full models.
Not investment advice.